These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20398348)

  • 1. The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.
    Barbi S; Cataldo I; De Manzoni G; Bersani S; Lamba S; Mattuzzi S; Bardelli A; Scarpa A
    J Exp Clin Cancer Res; 2010 Apr; 29(1):32. PubMed ID: 20398348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
    Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
    World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of PIK3CA mutations in gastric and colon cancer.
    Velho S; Oliveira C; Ferreira A; Ferreira AC; Suriano G; Schwartz S; Duval A; Carneiro F; Machado JC; Hamelin R; Seruca R
    Eur J Cancer; 2005 Jul; 41(11):1649-54. PubMed ID: 15994075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene.
    Polom K; Marrelli D; Roviello G; Pascale V; Voglino C; Vindigni C; Generali D; Roviello F
    Adv Clin Exp Med; 2018 Jul; 27(7):963-969. PubMed ID: 29905413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
    BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
    Catasus L; Gallardo A; Cuatrecasas M; Prat J
    Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of PIK3CA in gastric adenocarcinoma.
    Li VS; Wong CW; Chan TL; Chan AS; Zhao W; Chu KM; So S; Chen X; Yuen ST; Leung SY
    BMC Cancer; 2005 Mar; 5():29. PubMed ID: 15784156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
    Barbareschi M; Buttitta F; Felicioni L; Cotrupi S; Barassi F; Del Grammastro M; Ferro A; Dalla Palma P; Galligioni E; Marchetti A
    Clin Cancer Res; 2007 Oct; 13(20):6064-9. PubMed ID: 17947469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas.
    Rudd ML; Price JC; Fogoros S; Godwin AK; Sgroi DC; Merino MJ; Bell DW
    Clin Cancer Res; 2011 Mar; 17(6):1331-40. PubMed ID: 21266528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
    Liao X; Morikawa T; Lochhead P; Imamura Y; Kuchiba A; Yamauchi M; Nosho K; Qian ZR; Nishihara R; Meyerhardt JA; Fuchs CS; Ogino S
    Clin Cancer Res; 2012 Apr; 18(8):2257-68. PubMed ID: 22357840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.
    Guedes JG; Veiga I; Rocha P; Pinto P; Pinto C; Pinheiro M; Peixoto A; Fragoso M; Raimundo A; Ferreira P; Machado M; Sousa N; Lopes P; Araújo A; Macedo J; Alves F; Coutinho C; Henrique R; Santos LL; Teixeira MR
    BMC Cancer; 2013 Apr; 13():169. PubMed ID: 23548132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CA mutations in advanced cancers: characteristics and outcomes.
    Janku F; Wheler JJ; Naing A; Stepanek VM; Falchook GS; Fu S; Garrido-Laguna I; Tsimberidou AM; Piha-Paul SA; Moulder SL; Lee JJ; Luthra R; Hong DS; Kurzrock R
    Oncotarget; 2012 Dec; 3(12):1566-75. PubMed ID: 23248156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
    Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational hotspot in exon 20 of PIK3CA in breast cancer among Singapore Chinese.
    Liang X; Lau QC; Salto-Tellez M; Putti TC; Loh M; Sukumar S
    Cancer Biol Ther; 2006 May; 5(5):544-8. PubMed ID: 16582596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
    Dirican E; Kaya Z; Gullu G; Peker I; Ozmen T; Gulluoglu BM; Kaya H; Ozer A; Akkiprik M
    Asian Pac J Cancer Prev; 2014; 15(21):9327-33. PubMed ID: 25422220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.
    Schönleben F; Qiu W; Allendorf JD; Chabot JA; Remotti HE; Su GH
    J Gastrointest Surg; 2009 Aug; 13(8):1510-6. PubMed ID: 19440799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
    Harada K; Baba Y; Shigaki H; Ishimoto T; Miyake K; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwatsuki M; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
    BMC Cancer; 2016 Jul; 16():400. PubMed ID: 27388016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer.
    Iranpour M; Nourian M; Saffari S; Samizadeh E; Mirghafori M; Iravani S; Ghafouri-Fard S
    Iran Biomed J; 2019 Jan; 23(1):87-91. PubMed ID: 29704890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon 9 Mutation of
    Seo AN; Kang BW; Bae HI; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Jeon SW; Kang H; Kim JG
    Anticancer Res; 2019 Apr; 39(4):2145-2154. PubMed ID: 30952761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.